Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Baseline resistance and virological outcome in patients with virological failure who start a regimen containing abacavir: EuroSIDA study.

Antiviral therapy - 1 Oct 2004

Cabrera Cecilia, Cozzi-Lepri Alessandro, Phillips Andrew N, Loveday Clive, Kirk Ole, Ait-Khaled Mounir, Reiss Peter, Kjaer Jesper, Ledergerber Bruno, Lundgren Jens D, Clotet Bonaventura, Ruiz Lidia

Abstract excerpt

OBJECTIVES: To investigate the ability of several HIV-1 drug-resistance interpretation systems, as well as the number of pre-specified combinations of abacavir-related mutations, to predict virological response to abacavir-containing regimens in antiretroviral therapy-experienced, abacavir-naive patients starting an abacavir-containing regimen in the EuroSIDA cohort. PATIENTS AND METHODS: A total of 100...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-HIV Agents
Share to Dideoxynucleosides

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Resistance, Viral

Share to Drug Therapy, Combination

Share to HIV Infections

Share to Logistic Models

Share to Reverse Transcriptase Inhibitors

Share to Treatment Failure

Source

Identifiers

PMID: 15535417

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Baseline resistance and virological outcome in patients with virological failure who start a regimen containing abacavir: EuroSIDA study.PMID 15535417Read ↗

Initiatives for developing and comparing genotype interpretation systems: external validation of existing rule-based interpretation systems for abacavir against virological response.Semantic proximity Read ↗

Interpreting resistance data for HIV-1 therapy management--know the limitations.Semantic proximity Read ↗

Interpretation of genotypic resistance to predict darunavir/ritonavir failure in antiretroviral experienced patients.Semantic proximity Read ↗

Comparison of HIV-1 genotypic resistance test interpretation systems in predicting virological outcomes over time.Semantic proximity Read ↗

HIV-1 genotypic drug resistance interpretation rules - 2009 Spanish guidelines.Semantic proximity Read ↗

A genotypic drug resistance interpretation algorithm that significantly predicts therapy response in HIV-1-infected patients.Semantic proximity Read ↗

HIV-1 drug-resistance patterns among patients on failing treatment in a large number of European countries.Semantic proximity Read ↗

Virological response to darunavir/ritonavir-based regimens in antiretroviral-experienced patients (PREDIZISTA study).Semantic proximity Read ↗

Algorithms for the interpretation of HIV-1 genotypic drug resistance information.Semantic proximity Read ↗

Improved interpretation of genotypic changes in the HIV-1 reverse transcriptase coding region that determine the virological response to didanosine.Semantic proximity Read ↗

Construction, training and clinical validation of an interpretation system for genotypic HIV-1 drug resistance based on fuzzy rules revised by virological outcomes.Semantic proximity Read ↗

Algorithm evolution for drug resistance prediction: comparison of systems for HIV-1 genotyping.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.